Tianjing Biological

Developer of immuno-oncology drugs for treating cancer and autoimmune diseases

placeShanghai, Shanghai, China calendar_todayFounded 2014 groups318 employees language i-mabbiopharma.com

Registered entities

Social engagement

Social engagement: 5.6K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

21 investors on record; lead investors include Hony Capital.

Investor typeCountShare
Venture capital419%
Private equity1362%
Bank & private debt15%
Other / undisclosed314%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

13 Oct 2025 · Executive Assistant to Executive Chairman · Shanghai

Based on job postings tracked across public sources.

Recent activity

14 Oct 2025
Event
AACR-NCI-EORTC Molecular Targets and Cancer Therapeutics Conference 2025
5 Sep 2025
Event
HCWainwright & Co. 27th Annual Global Investment Conference
2 Sep 2025
Event
Cantor Annual Global Healthcare Conference
Coming soon